L472-1037 Screening compound: 3-{3-[4-(2-ethyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole

L472-1037 Screening compound: 3-{3-[4-(2-ethyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole
L472-1037 Screening compound: 3-{3-[4-(2-ethyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L472-1037
3-{3-[4-(2-ethyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L472-1037

Molecular Formula

C20H19N5OS (C20 H19 N5 OS)

Compound Name

3-{3-[4-(2-ethyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole

IUPAC name

3-{3-[4-(2-ethyl-13-thiazol-4-yl)phenyl]-124-oxadiazol-5-yl}-4567-tetrahydro-1H-indazole

SMILES

CCc1nc(-c(cc2)ccc2-c2noc(-c3n[nH]c4c3CCCC4)n2)cs1

InChI

InChI=1S/C20H19N5OS/c1-2-17-21-16(11-27-17)12-7-9-13(10-8-12)19-22-20(26-25-19)18-14-5-3-4-6-15(14)23-24-18/h7-11H,2-6H2,1H3,(H,23,24)

InChI Key

IAAVPWXTUMFNHF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27455037

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

377.47

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.383

Distribution Coefficient, logD

5.383

Water Solubility, LogSw

-5.37

Polar Surface Area

66.827

Acid Dissociation Constant (pKa)

14.65

Base Dissociation Constant (pKb)

0.53

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

L472-1037 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with L472-1037 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L472-1037?
Check Price and Availability of L472-1037, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L472-1037 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L472-1037
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L472-1037
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L472-1037 available by request